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General Procedures. All reactions were performed in oven-dried or flame-dried round-bottomed 
flasks or in oven-dried 5 mm o.d. NMR tubes.  The flasks were fitted with rubber septa and reactions 
were conducted under a positive pressure of argon.  Stainless steel syringes or cannulae were used to 
transfer air- and moisture-sensitive liquids. Where necessary (so noted), solutions were deoxygenated 
by bubbling through with balloon-pressure argon through for the time stated.  Where noted, 
compounds were dried azeotropically by concentrating three times from benzene under high-vacuum 
(0.1 Torr), refilling the flask with argon between each cycle.  Flash column chromatography was 
performed as described by Still et al. using silica gel (60-Å pore size, 32–63 µm, standard grade).1   
Analytical thin–layer chromatography was performed using glass plates pre-coated with 0.25 mm 
230–400 mesh silica gel impregnated with a fluorescent indicator (254 nm).  Thin layer 
chromatography plates were visualized by exposure to ultraviolet light and an aqueous solution of 
ceric ammonium molybdate (CAM).  Organic solutions were concentrated on rotary evaporators at 
~20 Torr (house vacuum) at 25–35 °C.  
Materials.  Commercial reagents and solvents were used as received with the following exceptions: 
                                                
1 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925. 
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dichloromethane, diethyl ether, tetrahydrofuran, and triethylamine were purified by the method of 
Grubbs et al. under positive argon pressure.2 Dimethylsulfoxide (>99.9 % HPLC grade, ≤0.020 % 
water) was used as received.  Benzene and 2,6-lutidine were distilled over calcium hydride, and 
dimethylformamide was distilled over calcium sulfate under reduced pressure.  Triethylsilyl 
trifluoromethanesulfonate and triisopropyl trifluoromethanesulfonate were distilled under reduced 
pressure.  Deuterated solvents were used as received. 
Instrumentation. Proton nuclear magnetic resonance (1H NMR) spectra were recorded with an 
inverse probe 500 MHz, a 500 MHz, or an inverse probe 600 MHz spectrometer, are recorded in parts 
per million from internal tetramethylsilane on the δ scale and are referenced from the residual protium 
in the NMR solvent (C6D5H: δ 7.16, CHCl3: δ 7.27).  Data is reported as follows: chemical shift 
[multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant(s) in 
Hertz, integration, assignment].  Carbon-13 nuclear magnetic resonance (13C NMR) spectra were 
recorded with a 500 MHz spectrometer, are recorded in parts per million from internal 
tetramethylsilane on the δ scale, and are referenced from the carbon resonances of the solvent (C6D6: δ 
128.39, CDCl3: δ 77.23). Infrared data (IR) are reported as follows: frequency of absorption (cm–1), 
intensity of absorption (s = strong, m = medium, w = weak, br = broad). High resolution mass spectra 
were obtained using a Fourier transform ion cyclotron resonance mass spectrometer with electrospray 
ionization. 
Compound Numbering.  The numbering system for proton and carbon assignments for all 
pyrroloindolizine structures is consistent with the isolation reports for the naturally occurring tricyclic 
myrmicarins.3 The numbering system for proton and carbon assignments for all heterodimeric 
structures is consistent with the isolation reports for myrmicarin 430A4 and the numbering system of 
isomyrmicarin 430A.5 
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2 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518–1520. 
3 Schröder, F.; Franke, S.; Francke, W. Tetrahedron 1996, 52, 13539–13546. 
4 Schröder, F.; Sinnwell, V.; Baumann, H.; Kaib, M. Chem. Commun. 1996, 2139–2140. 
5 Ondrus, A. E.; Movassaghi, M. Tetrahedron 2006, 62, 5287–5297. 
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32 33  (1-Ethyl-2-propionyl-5,6,7,8-tetrahydro-indolizin-5-yl)-acetaldehyde (33): 
 A solution of 2-iodoxybenzoic acid6 (IBX, 620 mg, 2.21 mmol, 1.10 equiv) in anhydrous 
dimethylsulfoxide (DMSO, 2.50 mL) was prepared by sonicating the initial suspension for 30 min, 
and this solution was then degassed (argon purge, 10 min).  The solution of IBX was added dropwise 
via cannula to an anhydrous and degassed (argon purge, 10 min) solution of alcohol 327 (502 mg, 
2.01 mmol, 1 equiv) in dimethylsulfoxide (10.0 mL), causing the solution to turn deep rose within 2 
min.  After 1 h, an additional portion of 2-iodoxybenzoic acid (620 mg, 2.21 mmol, 1.10 equiv) in 
dimethylsulfoxide (2.50 mL) was prepared and degassed as above and added to the reaction mixture 
via cannula.  After an additional 2 h, the deep rose solution was partitioned between diethyl ether (10 
mL) and a mixture of saturated aqueous sodium thiosulfate solution and saturated aqueous sodium 
bicarbonate solution (10:1, 10 mL).  The resulting mixture was diluted with additional portions of 
diethyl ether (70 mL) and saturated aqueous sodium thiosulfate solution-saturated aqueous sodium 
bicarbonate solution (10:1, 60 mL), then the aqueous phase was separated from the clear, pale yellow 
organic phase and extracted with diethyl ether (5 × 60 mL).  The combined organic phases were 
washed with brine (50 mL), were dried over anhydrous sodium sulfate, and were concentrated in 
vacuo.  The resulting brown residue was purified by flash column chromatography on silica gel 
(eluent: 2.5% triethylamine and 32.5 → 57.5% ethyl acetate in hexanes, diameter: 4.0 cm, height: 6.0 
cm) to afford the aldehyde 33 as a pale yellow oil (408 mg, 82%). 
1H NMR (500 MHz, C6D6, 20°C): 9.02 (t, J =1.1 Hz, 1H, CHO), 6.77 (s, 1H, NCH=C), 
3.99 (ddd, J = 11.3, 6.7, 5.1 Hz, 1H, NCHCH2), 2.93–
3.04 (m, 2H, CCH2CH3), 2.23 (m, 2H, NCCH2CH2), 
2.03 (ddd, J = 18.2, 5.1, 1.1 Hz, 1H, NCHCH2CHO), 
1.83 (ddd, J = 18.2, 6.7, 1.1 Hz, 1H, NCHCH2CHO), 
1.41 (t, J = 7.5 Hz, 3H, CCH2CH3), 1.36–1.40 (m, 1H, 
NCHCH2CH2), 1.26 (t, J = 7.4 Hz, 3H, COCH2CH3), 
1.00–1.24 (m, 3H, NCHCH2CH2, NCHCH2CH2). 
13C NMR (125.8 MHz, C6D6, 20°C): 198.5, 196.1, 128, 127.3, 123.5, 122.7, 50.4, 49.3, 33.3, 
29.4, 21.5, 19.0, 18.5, 16.1, 9.7. 
FTIR (neat) cm–1: 2936 (s, C–H), 2730 (m, C–H), 1723 (s, C=O), 1688 (s, 
C=O), 1650 (s), 1516 (m), 1380 (m). 
 
HRMS–EI (m/z): calcd for C15H22NO2 [M + H]+: 248.1645, 
  found: 248.1654. 
TLC (silica gel, 50% EtOAc–hexanes), Rf: 0.39 (UV, CAM). 
                                                
6 Prepared according to the procedure of Frigerio, M.; Santagostino, M.; Sputore, S. J. Org. Chem. 1999, 64, 4537-4538. 
7 Movassaghi, M.; Ondrus, A. E. Org. Lett. 2005, 7, 4423–4426. 
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1-(1-Ethyl-3-hydroxy-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl)-propan-1-one (35): 
 Triethylsilyl trifluoromethanesulfonate (TESOTf, 1.08 mL, 4.79 mmol, 3.30 equiv) was added 
dropwise via syringe to a colorless and anhydrous solution of aldehyde 33 (358 mg, 1.45 mmol, 1 
equiv) and 2,6-lutidine (845 µL, 7.25 mmol, 5.00 equiv) in benzene (30.0 mL), producing an intense 
yellow solution.  After 15 min, the reaction flask was placed on an ice-water bath for 3 min, then 
saturated aqueous sodium bicarbonate solution (35 mL) was added and the reaction flask was 
immediately removed from the ice-water bath.  This mixture was diluted with diethyl ether (60 mL) 
and the aqueous phase was separated from the yellow organic phase and extracted with diethyl ether 
(3 × 20 mL). Aqueous hydrochloric acid solution (1N, 100 mL) was added to the combined organic 
phases and the biphasic mixture was agitated thoroughly (~3 min) in a separatory funnel until TLC 
analysis indicated that the C8-C9 silyl enol ethers had been completely hydrolyzed to the C8 ketone.  
The aqueous phase was separated from the yellow organic phase and extracted with diethyl ether (2 × 
30 mL), then the combined organic phases were washed sequentially with saturated aqueous sodium 
bicarbonate solution (35 mL) and brine (35 mL), were dried over anhydrous sodium sulfate, were 
filtered, and were concentrated under reduced pressure to give crude 34 and S1.  
 Tetrabutylammonium fluoride (TBAF, 1.0 M in tetrahydrofuran, 5.08 mL, 5.08 mmol, 3.50 
equiv) was added via syringe to a solution of the crude yellow residue in tetrahydrofuran (THF, 7.25 
mL) at 0 °C in an ice-water bath.  After 15 min, ethyl acetate (5 mL) and water (5 mL) were added 
simultaneously and the reaction flask was immediately removed from the ice-water bath.  The 
mixture was diluted with additional portions of ethyl acetate (30 mL), water (10 mL), and brine (1.5 
mL).  The aqueous phase was separated from the yellow organic phase and extracted with ethyl 
acetate (5 × 15 mL).  The combined organic phases were washed with brine (15 mL), were dried over 
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure to give a 
yellow residue.  This residue was purified by flash column chromatography on silica gel (eluent: 45 
→ 75% ethyl acetate in hexanes, diameter: 4.0 cm, height: 23 cm) to afford the tricyclic alcohols 35 
(237 mg, 66%) and S2 (52.3 mg, 15%) as white powders. 
 
Ketone 34: 
1H NMR (500 MHz, C6D6, 20°C): 5.17 (dd, J = 7.6, 6.1 Hz, 1H, C3–H), 3.32 (dq, J = 16.8, 
7.4 Hz, 1H, C9–H), 3.08–3.18 (m, 2H, C11–H, C11–
H’), 2.92 (tdd, J = 10.8, 5.4, 3.2 Hz, 1H, C4a–H), 2.86 
(dq, J = 16.8, 7.3 Hz, 1H, C9–H’), 2.43 (ddd, J = 16.4, 
6.5, 1.1 Hz, 1H, C7–Hc), 2.31 (dt, J = 11.7, 5.7 Hz, 1H, 
C4–Hc), 2.17 (ddd, J = 16.3, 12.0, 6.9 Hz, 1H, C7–Ht), 
1.70 (ddd, J = 11.3, 10.5, 7.8 Hz, 1H, C4–Ht), 1.53–1.58 
(m, 1H, C6–Ht), 1.51 (t, J = 7.5 Hz, 3H, C12–H), 1.44 (t, 
J = 7.3 Hz, 3H, C10–H), 1.39 (dq, J = 12.5, 3.4 Hz, 1H, 
C5–Hc), 1.17 (tddd, J = 13.4, 12.3, 6.5, 2.8 Hz, 1H, C6–
Hc), 0.96 (t, J = 7.9 Hz, 9H, SiCH2CH3), 0.77 (tdd, J = 
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12.9, 11.2, 2.6 Hz, 1H, C5–Ht), 0.59 (q, J = 7.9 Hz, 6H, 
SiCH2CH3). 
13C NMR (125.8 MHz, C6D6, 20°C): 196.4, 137.1, 127.3, 120.2, 118.0, 72.4, 53.4, 47.5, 35.7, 
29.5, 22.2, 20.2, 19.9, 16.3, 9.3, 7.5, 5.7. 
FTIR (neat) cm–1: 2956 (s, C–H), 1650 (s, C=O), 1491 (m), 1321 (m), 1118 
(s). 
 
HRMS–EI (m/z): calcd for C21H35NO2SiNa [M + Na]+: 384.2329, 
  found: 384.2335. 
 
TLC (silica gel, 10% EtOAc–hexanes), Rf: 0.28 (UV, CAM). 
 
Tricyclic alcohol 35: 
1H NMR (500 MHz, C6D6, 23°C): 6.11 (s, 1H, C3–OH), 5.35 (dd, J = 8.2, 6.4 Hz, 1H, C3–
H), 2.92 (dddd, J = 11.2, 10.3, 5.2, 3.9 Hz, 1H, C4a–H), 
2.74 (dq, J = 17.2, 7.0 Hz, 1H, C11–H), 2.67 (dq, J = 
17.2, 7.0 Hz, 1H, C11–H’), 2.53 (dq, J = 10.7, 7.4 Hz, 
1H, C9–H), 2.52 (dq, J = 10.7, 7.4 Hz, 1H, C9–H’), 2.47 
(ddd, J = 11.7, 6.3, 5.4 Hz, 1H, C4–Hc), 2.31 (ddd, J = 
16.5, 6.7, 1.2 Hz, 1H, C7–Hc), 2.10 (ddd, J = 16.5, 11.9, 
7.0 Hz, 1H, C7–Ht), 1.90 (ddd, J = 11.8, 10.2, 8.2 Hz, 
1H, C4–Ht), 1.47 (ddddd, J = 13.9, 6.9, 4.1, 2.7, 1.4 Hz, 
1H, C6–Ht), 1.24 (t, J = 7.2 Hz, 3H, C12–H), 1.21–1.27 
(m, 1H, C5–Hc), 1.13 (t, J = 7.5 Hz, 3H, C10–H), 1.07 
(tddd, J = 13.5, 11.8, 6.6, 2.7 Hz, 1H, C6–Hc), 0.66 (tdd, 
J = 12.9, 11.3, 2.6 Hz, 1H, C5–Ht). 
nOe data (500 MHz, C6D6, 20°C):  
N
Me
Me
H
O
HO
H 4
3
4a
H
H2.8% nOe
0.5% nOe
1.1% nOe
35
 
13C NMR (125.8 MHz, CDCl3, 20°C): 201.0, 142.9, 123.8, 121.6, 118.0, 70.3, 56.0, 46.3, 34.3, 
30.1, 22.4, 20.5, 20.1, 16.7, 9.1. 
FTIR (neat) cm–1: 3346 (m, O–H), 2942 (m, C–H), 1609 (s, C=O), 1498 
(s), 1452 (m), 1253 (m). 
 
HRMS–EI (m/z): calcd for C15H21NO2Na [M + Na]+: 270.1464, 
  found: 270.1461. 
TLC (silica gel, 60% EtOAc–hexanes), Rf: 0.57 (UV, CAM). 
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 1-[1-Ethyl-3-(triisopropyl-silanyloxy)-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl]-propan-1-
one (36):  Triisopropyl trifluoromethanesulfonate (TIPSOTf, 500 µL, 1.86 mmol, 2.26 equiv) was 
added dropwise via syringe to a clear yellow solution of tricyclic alcohol 35 (204 mg, 825 µmol, 1 
equiv) and 2,6-lutidine (480 µL, 4.12 mmol, 5.00 equiv) in dichloromethane (12.0 mL) at –40 °C.  
The resulting intense yellow solution was maintained at –40 °C for 2 min, and then the reaction flask 
was placed on an ice-water bath.  After 15 min, saturated aqueous sodium bicarbonate solution (15 
mL) was added and the reaction flask was removed from the ice water bath.  The mixture was diluted 
with diethyl ether (50 mL) and the layers were separated.  The yellow organic phase was extracted 
with diethyl ether (3 × 15 mL).  Aqueous hydrochloric acid solution (1N, 60 mL) was added to the 
combined organic phases and the biphasic mixture was agitated thoroughly (~8 min) in a separatory 
funnel until TLC analysis indicated that the C8-C9 silyl enol ether had been completely converted to 
the C8 ketone 36.  The aqueous phase was extracted with diethyl ether (2 × 30 mL), and the 
combined organic phases were washed sequentially with saturated aqueous sodium bicarbonate 
solution (25 mL) and brine (25 mL), were dried over anhydrous sodium sulfate, were filtered, and 
were concentrated under reduced pressure to a yellow residue.  This residue was purified by flash 
column chromatography on silica gel (eluent: 3.5% triethylamine, 1% ethyl acetate, and 6% 
dichloromethane in hexanes, diameter: 4.0 cm, height: 19 cm) to afford the triisopropylsilyl ether 36 
(273 mg, 82%) as a white powder. 
1H NMR (500 MHz, C6D6, 20°C): 5.38 (dd, J = 7.8, 6.1 Hz, 1H, C3–H), 3.38 (dq, J = 17.1, 
7.3 Hz, 1H, C9–H), 3.16 (dq, J = 13.7, 7.0 Hz, 1H, C11–
H), 3.04 (dq, J = 13.7, 7.1 Hz, 1H, C11–H’), 2.91 (dq, J 
= 17.1, 7.3 Hz, 1H, C9–H’), 2.89 (tdd, J = 10.7, 5.4, 3.3 
Hz, 1H, C4a–H), 2.43 (ddd, J = 16.1, 6.6, 1.1 Hz, 1H, 
C7–Hc), 2.41 (dt, J = 11.4, 5.7 Hz, 1H, C4–Hc), 2.17 
(ddd, J = 16.3, 12.2, 6.9 Hz, 1H, C7–Ht), 1.79 (ddd, J = 
11.3, 10.5, 7.8 Hz, 1H, C4–Ht), 1.56 (ddddd, J = 13.7, 
6.8, 4.1, 2.7, 1.4 Hz, 1H, C6–Ht), 1.49 (t, J = 7.4 Hz, 3H, 
C12–H), 1.44 (t, J = 7.3 Hz, 3H, C10–H), 1.40–1.45 (m, 
1H, C5–Hc), 1.19 (tddd, J = 13.4, 12.2, 6.5, 2.9 Hz, 1H, 
C6–Hc), 1.01–1.12 (m, 21H, SiCH(CH3)3, SiCH(CH3)3), 
0.84 (tdd, J = 12.8, 11.2, 2.6 Hz, 1H, C5–Ht). 
13C NMR (125.8 MHz, C6D6, 20°C): 196.5, 137.0, 127.0, 120.0, 118.2, 73.3, 53.2, 47.4, 35.8, 
29.6, 22.2, 20.1, 20.0, 18.7, 18.6, 16.4, 13.6, 9.1. 
FTIR (neat) cm–1: 2867 (s, C–H), 1650 (s, C=O), 1489 (s), 1256 (m), 1123 
(m). 
HRMS–EI (m/z): calcd for C24H41NO2SiNa [M + Na]+: 426.2799, 
  found: 426.2791. 
TLC (silica gel, 12.5% EtOAc–hexanes), Rf: 0.33 (UV, CAM). 
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 1-[1-Ethyl-3-(triisopropyl-silanyloxy)-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl]-2-hydroxy-
propan-1-one (37):  An anhydrous solution of triisopropylsilyl ether 36 (99.8 mg, 247 µmol, 1 equiv) 
in tetrahydrofuran (1050 µL + 2 × 250 µL) was added dropwise via cannula to a solution of 
potassium hexamethyldisilazane (KHMDS, 173 mg, 865 µmol, 3.50 equiv) in tetrahydrofuran (700 
µL) at –78 °C.  After the addition was complete, the reaction flask was placed on an ice-water bath 
for 5 min, and then moved to a dry ice-acetone bath at –78 °C for 5 min.  A solution of (±)-trans-2-
(phenylsulfonyl)-3-phenyloxaziridine8 (32.4 mg, 124 µmol, 0.500 equiv) in tetrahydrofuran (280 µL) 
was then added dropwise via syringe to the clear yellow reaction mixture.  An additional four 
portions of (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine (4 × 8.05 mg, 30.9 µmol, 0.125 equiv) 
in tetrahydrofuran (70.0 µL) were added every 5 min and the progress of the reaction was monitored 
by TLC analysis after the addition of each portion.  Five min after adding the last portion, ethyl 
acetate (3 mL) and a mixture of saturated aqueous sodium thiosulfate solution and saturated aqueous 
sodium bicarbonate solution (3:2, 3 mL) were added simultaneously, and the reaction flask was 
immediately removed from the dry ice-acetone bath.  The mixture was diluted with additional 
portions of ethyl acetate (27 mL) and saturated aqueous sodium thiosulfate solution-satuated aqueous 
sodium bicarbonate solution (3:2, 22 mL) and the aqueous phase was separated from the yellow 
organic phase and extracted with ethyl acetate (3 × 22.5 mL).  The combined organic phases were 
washed with a mixture of brine and saturated aqueous sodium thiosulfate solution (10:1, 15 mL), 
were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced 
pressure to ~500-µL volume.  This crude sample was subjected to flash column chromatography on 
silica gel (eluent: 15% ethyl acetate in hexanes, diameter: 3.0 cm, height 25 cm) to afford the α-
hydroxy ketones 37 (78.0 mg, 75%) and 44 (17.5 mg, 17%) as white powders. 
 
α-Hydroxy Ketone 37: 
1H NMR (500 MHz, C6D6, 20°C): 5.47 (dq, J = 7.7, 6.7 Hz, 1H, C9–H), 5.13 (dd, J = 8.6, 
5.9 Hz, 1H, C3–H), 4.10 (d, J = 7.8 Hz, 1H, C9-OH), 
3.08 (dq, J = 13.9, 7.1 Hz, 1H, C11–H), 2.78 (dq, J = 
13.9, 7.2 Hz, 1H, C11–H’), 2.64 (tdd, J = 11.0, 5.1, 3.4 
Hz, 1H, C4a–H), 2.36 (ddd, J = 16.3, 6.3, 1.1 Hz, 1H, 
C7–Hc), 2.23 (dt, J = 11.2, 5.5 Hz, 1H, C4–Hc), 2.10 
(ddd, J = 16.4, 12.1, 6.7 Hz, 1H, C7–Ht), 1.74 (td, J = 
10.9, 8.6 Hz, 1H, C4–Ht), 1.57 (d, J = 6.7 Hz, 3H, C10–
H), 1.49 (ddddd, J = 13.7, 6.7, 4.0, 2.8, 1.3 Hz, 1H, C6–
Ht), 1.39 (t, J = 7.4 Hz, 3H, C12–H), 1.32 (dq, J = 12.5, 
3.3 Hz, 1H, C5–Hc), 1.09–1.17 (m, 1H, C6–Hc), 1.09–
1.17 (m, 21H, SiCH(CH3)3, SiCH(CH3)3), 0.74 (tdd, J = 
12.7, 11.5, 2.6 Hz, 1H, C5–Ht). 
                                                
8 (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine was prepared from N-benzylidenebenzenesulfonamide according to the procedure of 
Ruano, J. L. G.; Aleman, J.; Fajardo, C.; Parra, A. Org. Lett. 2005, 7, 5493–5496.  N-benzylidene-benzenesulfonamide was prepared 
according to the procedure of Vishwakarma, L. C.; Stringer, O. D.; Davis, F. A. Org. Syn. 1988, 66, 203–210. 
Efficient and Stereoselective Dimerization of Pyrroloindolizine Derivatives Inspired by a Hypothesis for the Biosynthesis of Page S8 / S70 
Complex Myrmicarin Alkaloids. 
Mohammad Movassaghi,* Alison E. Ondrus, and Bin Chen 
13C NMR (125.8 MHz, C6D6, 20°C): 201.2, 136.5, 127.5, 120.9, 115.5, 73.4, 71.6, 52.9, 46.3, 
29.0, 24.7, 22.1, 20.0, 19.7, 18.8, 18.6, 16.5, 13.7. 
FTIR (neat) cm–1: 3459 (m, O–H), 2945 (s, C–H), 1643 (s, C=O), 1461 
(m), 1117 (s). 
 
HRMS–EI (m/z): calcd for C24H41NO3SiNa [M + Na]+: 422.2748, 
  found: 422.2761. 
 
TLC (silica gel, 22.5% EtOAc–hexanes), Rf: 0.25 (UV, CAM). 
 
 
α-Hydroxy Ketone 44: 
1H NMR (500 MHz, C6D6, 20°C): 5.47 (dq, J = 7.2, 6.6 Hz, 1H, C9–H), 5.46 (dd, J = 7.8, 
6.1 Hz, 1H, C3–H), 4.50 (d, J = 6.4 Hz, 1H, C9-OH), 
3.11 (dq, J = 14.0, 7.1 Hz, 1H, C11–H), 2.86 (tdd, J = 
10.7, 5.2, 3.6 Hz, 1H, C4a–H), 2.80 (dq, J = 13.9, 7.2 
Hz, 1H, C11–H’), 2.40 (dt, J = 11.4, 5.7 Hz, 1H, C4–
Hc), 2.33 (ddd, J = 16.5, 6.6, 1.1 Hz, 1H, C7–Hc), 2.08 
(ddd, J = 16.6, 11.9, 6.9 Hz, 1H, C7–Ht), 1.74 (ddd, J = 
11.2, 10.4, 8.0 Hz, 1H, C4–Ht), 1.56 (d, J = 6.9 Hz, 3H, 
C10–H), 1.49 (ddddd, J = 13.8, 6.9, 4.1, 2.7, 1.3 Hz, 1H, 
C6–Ht), 1.35 (t, J = 7.5 Hz, 3H, C12–H), 1.33–1.39 (m, 
1H, C5–Hc), 1.07–1.15 (m, 1H, C6–Hc), 1.06–1.11 (m, 
21H, SiCH(CH3)3, SiCH(CH3)3), 0.75 (tdd, J = 12.9, 
11.3, 2.6 Hz, 1H, C5–Ht). 
13C NMR (125.8 MHz, C6D6, 20°C): 199.2, 138.2, 127.4, 120.9, 113.5, 73.3, 70.9, 53.7, 48.0, 
29.5, 24.4, 21.9, 20.0, 19.8, 18.7, 18.6, 16.1, 13.6. 
FTIR (neat) cm–1: 3450 (m, O–H), 2944 (s, C–H), 1643 (s, C=O), 1462 
(m), 1118 (s). 
 
HRMS–EI (m/z): calcd for C24H41NO3SiNa [M + Na]+: 442.2748, 
  found: 442.2750. 
TLC (silica gel, 22.5% EtOAc–hexanes), Rf: 0.32 (UV, CAM). 
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N
Me
H
O
iPr3SiO
PPh3, DEAD
4-nitrobenzoic acid
THF, 23 ! 45 °C, 5h
61%
(+ 11% 37)
S3
N
Me
H
O
iPr3SiO
37
O
O2N
O
HO
Me Me
 4-Nitro-benzoic acid 2-[1-ethyl-3-(triisopropyl-silanyloxy)-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-
cd]indolizin-2-yl]-1-methyl-2-oxo-ethyl ester (S3):  Diethyl azodicarboxylate (DEAD, 150 µL, 952 
µmol, 20.00 equiv) was added dropwise to a solution of triphenylphosphine (PPh3, 300 mg, 114 
µmol, 20.00 equiv) in tetrahydrofuran (600 µL) at 0 °C.  The reaction flask was removed from the 
cooling bath and the resulting pale yellow solution was stirred for 5 min.  This solution was drawn 
into a syringe and half of it (DEAD: 75.0 µL, 476 µmol, 10.00 equiv, PPh3: 150 mg, 57.2 µmol, 12.00 
equiv, tetrahydrofuran: 300 µL) was transferred to an anhydrous solution of α-hydroxy ketone 37 
(20.0 mg, 47.6 µmol, 1 equiv) and 4-nitrobenzoic acid (79.5 mg, 476 µmol, 10.00 equiv) in 
tetrahydrofuran (600 µL) at 23 °C.  The reaction flask was immediately placed on an oil bath at 45 
°C.  After 5h, the deep yellow solution was allowed to cool to room temperature and then diluted with 
ethyl acetate (15 mL), water (10 mL), and brine (1 mL).  The aqueous phase was separated from the 
yellow organic phase and extracted with ethyl acetate (3 × 10 mL).  The combined organic phases 
were washed with brine (7.5 mL), were dried over anhydrous sodium sulfate, were filtered, and were 
concentrated to a bright yellow residue.  This residue was purified by flash column chromatography 
on silica gel (eluent: 9 → 12.5% ethyl acetate and 18 → 25% dichloromethane in hexanes, diameter: 
2.5 cm, height: 22 cm) to afford the 4-nitrobenzoyl ester S3 (16.4 mg, 61%) as a pale yellow oil, 
along with recovered α-hydroxy ketone 37 (3.1 mg, 11%). 
1H NMR (500 MHz, C6D6, 20°C): 7.94 (d, J = 9.0 Hz, 2H, NO2CCH), 7.64 (d, J = 9.0 Hz, 
2H, NO2CCHCH), 6.57 (q, J = 7.0 Hz, 1H, C9–H), 5.43 
(dd, J = 8.3, 5.8 Hz, 1H, C3–H), 3.03 (dq, J = 13.9, 7.1 
Hz, 1H, C11–H), 2.89 (dq, J = 13.9, 7.1 Hz, 1H, C11–
H’), 2.84 (tdd, J = 10.9, 5.2, 3.9 Hz, 1H, C4a–H), 2.42 
(dt, J = 11.1, 5.6 Hz, 1H, C4–Hc), 2.35 (ddd, J = 16.4, 
6.4, 1.6 Hz, 1H, C7–Hc), 2.10 (ddd, J = 16.5, 12.1, 6.6 
Hz, 1H, C7–Ht), 1.80 (td, J = 10.9, 8.4 Hz, 1H, C4–Ht), 
1.72 (d, J = 6.9 Hz, 3H, C10–H), 1.50–1.56 (m, 1H, C6–
Ht), 1.40 (t, J = 7.5 Hz, 3H, C12–H), 1.37–1.43 (m, 1H, 
C5–Hc), 1.07–1.18 (m, 1H, C6–Hc), 1.05–1.16 (m, 21H, 
SiCH(CH3)3, SiCH(CH3)3), 0.81 (tdd, J = 12.9, 11.3, 2.6 
Hz, 1H, C5–Ht). 
13C NMR (125.8 MHz, C6D6, 20°C): 191.3, 164.4, 150.8, 137.5, 136.3, 131.2, 128.9, 127.7, 
123.6, 120.8, 114.4, 75.8, 73.8, 53.3, 47.4, 29.4, 21.9, 
20.3, 19.8, 19.2, 18.9, 18.8, 16.1, 13.9. 
FTIR (neat) cm–1: 2946 (m, C–H), 1728 (s, C=O), 1660 (s, C=O), 1529 (s), 
1276 (s). 
HRMS–EI (m/z): calcd for C31H44N2O6SiNa [M + Na]+: 591.2861, 
  found: 591.2867. 
TLC (silica gel, 10% EtOAc, 20% CH2Cl2–hexanes), Rf:  0.42 (UV, CAM). 
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O
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 1-[1-Ethyl-3-(triisopropyl-silanyloxy)-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl]-2-hydroxy-
propan-1-one (44):  Aqueous lithium hydroxide solution (LiOH, 3.5 M, 465 µL, 9.98 equiv) was 
added via syringe to a solution of 4-nitrobenzoyl ester S3 (26.5 mg, 46.6 µmol, 1 equiv) in 
tetrahydrofuran (3.10 mL).  The reaction flask was placed on an oil bath at 55 °C and the mixture was 
stirred vigorously, producing a finely dispersed suspension.  After 12 h, the suspension was allowed 
to cool to room temperature then diluted with ethyl acetate (10 mL), water (6 mL), and brine (0.5 
mL).  The aqueous phase was separated and extracted with ethyl acetate (3 × 7.5 mL).  The combined 
organic phases were washed with brine (5 mL), were dried over anhydrous sodium sulfate, were 
filtered, and were concentrated under reduced pressure to provide the α-hydroxy ketone 44 (19.6 mg, 
100%) as an off-white solid.  See the procedure on page S8 for characterization data.  
                                     
N
Me
H
O
HO
TBAF, THF
0 °C, 10 min
92%
38
N
Me
H
O
iPr3SiO
37
HO HO
Me Me
 1-(1-Ethyl-3-hydroxy-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl)-2-hydroxy-propan-1-one 
(38):  Tetrabutylammonium fluoride (TBAF, 1.0 M in tetrahydrofuran, 270 µL, 270 µmol, 1.50 equiv) 
was added via syringe to a solution of  α-hydroxy ketone 37 (75.2 mg, 179 µmol, 1 equiv) in 
tetrahydrofuran (3.60 mL) at 0 °C.  After 10 min, chloroform (5 mL) and water (5 mL) were added 
simultaneously to the pale yellow solution and the reaction flask was immediately removed from the 
cooling bath.  The mixture was diluted with additional portions of chloroform (7.5 mL) and brine (1.5 
mL), and the aqueous phase was separated and extracted with chloroform (5 × 4 mL).  The combined 
organic phases were washed with brine (5 mL), were dried over anhydrous sodium sulfate, were 
filtered, and were concentrated under reduced pressure to a pale yellow residue.  This residue was 
purified by flash column chromatography on silica gel (eluent: 65 → 80% ethyl acetate in hexanes, 
diameter: 2.5 cm, height: 3.5 cm) to give the diol 38 (43.3 mg, 92%) as a white powder. 
1H NMR (500 MHz, CDCl3, 20°C): 5.52 (s, 1H, C3-OH), 5.41 (dd, J = 7.9, 6.5 Hz, 1H, C3–
H), 4.87 (pentet, J = 6.8 Hz, 1H, C9–H), 3.98 (d, J = 6.6 
Hz, 1H, C9-OH), 3.92 (dddd, J = 11.3, 10.2, 5.4, 3.8 Hz, 
1H, C4a–H), 3.05 (dt, J = 12.0, 6.0 Hz, 1H, C4–Hc), 
2.79 (ddd, J = 16.5, 6.3, 1.1 Hz, 1H, C7–Hc), 2.58 (q, J = 
7.6 Hz, 2H, C11–H), 2.52 (ddd, J = 16.6, 11.9, 6.4 Hz, 
1H, C7–Ht), 2.15–2.22 (m, 2H, C5–Hc, C6–Ht), 2.12 
(ddd, J = 12.0, 10.2, 8.1 Hz, 1H, C4–Ht), 1.76 (tddd, J = 
14.2, 9.8, 5.1, 2.1 Hz, 1H, C6–Hc), 1.47 (dtd, J = 17.1, 
12.7, 2.8 Hz, 1H, C5–Ht), 1.45 (d, J = 6.9 Hz, 3H, C10–
H), 1.15 (t, J = 7.5 Hz, 3H, C12–H). 
13C NMR (125.8 MHz, CDCl3, 20°C): 201.2, 144.6, 123.7, 122.5, 113.8, 70.6, 70.3, 56.2, 46.0, 
29.9, 23.7, 22.3, 20.6, 20.1, 16.3. 
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FTIR (neat) cm–1: 3358 (s, O–H), 2927 (s, C–H), 1638 (s, C=O), 1449 (s), 
1089 (s). 
HRMS–EI (m/z): calcd for C15H21NO3Na [M + Na]+: 286.1414, 
  found: 286.1421. 
TLC (silica gel, 75% EtOAc–hexanes), Rf: 0.30 (UV, CAM). 
 
                                           
N
Me
H
O
O
iPr2SiCl2, DMAP
DMF, 23 °C, 1 h
77%
39
N
Me
H
O
HO
38
HO O
iPr2Si
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 [1,3,2]-Dioxasilocine ketone 39: 
 Diisopropyldichlorosilane (iPr2SiCl2, 44.5 µL, 247 µmol, 1.50 equiv) was added dropwise via 
syringe to a solution of diol 38 (43.3 mg, 164 µmol, 1 equiv) and 4-(dimethylamino)pyridine 
(DMAP, 70.1 mg, 574 µmol, 3.50 equiv) in dimethylformamide (DMF, 4.30 mL) at 23 °C.  After 1 h, 
diethyl ether (17.5 mL) and a mixture of water and saturated aqueous sodium bicarbonate solution 
(3:1, 15 mL) were added and the aqueous phase was separated from the organic phase and extracted 
with diethyl ether (5 × 10 mL).  The combined organic phases were washed with brine (10 mL), were 
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure. 
The crude residue was purified by flash column chromatography on silica gel (eluent: 2.5% 
triethylamine and 5% ethyl acetate in hexanes, diameter 3.0 cm, height 5.5 cm) to provide the 
diisopropylsilyl tethered diol 39 (47.8 mg, 77%) as a colourless oil. 
1H NMR (500 MHz, C6D6, 20°C): 5.45 (dd, J = 8.5, 6.2 Hz, 1H, C3–H), 4.88 (q, J = 6.5 
Hz, 1H, C9–H), 3.22 (dq, J = 13.9, 7.0 Hz, 1H, C11–H), 
3.01 (dq, J = 13.8, 7.0 Hz, 1H, C11–H’), 2.92 (tdd, J = 
10.9, 4.9, 3.7 Hz, 1H, C4a–H), 2.44 (ddd, J = 16.5, 6.5, 
1.0 Hz, 1H, C7–Hc), 2.38 (dt, J = 11.5, 5.7 Hz, 1H, C4–
Hc), 2.19 (ddd, J = 16.5, 12.0, 6.9 Hz, 1H, C7–Ht), 1.95 
(ddd, J = 11.5, 10.7, 8.6 Hz, 1H, C4–Ht), 1.71 (d, J = 6.6 
Hz, 3H, C10–H), 1.54 (t, J = 7.4 Hz, 3H, C12–H), 1.34–
1.39 (m, 1H, C5–Hc), 1.51–1.57 (m, 1H, C6–Ht), 1.23–
1.30 (m, 6H, SiCH(CH3)3), 1.14–1.18 (m, 3H, 
SiCH(CH3)3), 1.10–1.18 (m, 1H, C6–Hc), 1.10–1.14 (m, 
3H, SiCH(CH3)3), 1.09–1.25 (m, 2H, SiCH(CH3)3), 0.76 
(tdd, J = 12.5, 11.5, 2.7 Hz, 1H, C5–Ht). 
13C NMR (125.8 MHz, C6D6, 20°C): 197.0, 137.9, 128, 120.7, 114.3, 76.1, 72.7, 53.4, 46.0, 
29.4, 22.3, 22.1, 20.4, 20.0, 18.4, 18.2, 18.0, 17.9, 16.5, 
12.9, 12.5. 
FTIR (neat) cm–1: 2946 (s), 1644 (s, C=O), 1463 (s), 1321 (s), 1119 (s). 
HRMS–EI (m/z): calcd for C21H33NO3SiNa [M + Na]+: 398.2122, 
  found: 398.2128. 
TLC (silica gel, 12.5% EtOAc–hexanes), Rf:  0.30 (UV, CAM). 
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[1,3,2]-Dioxasilocine alcohol 40: 
N
Me
Me
H
O
O
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77%
39
O
iPr2Si
N
Me
H
O
40: R1 = OH, R2 = H
S4: R1 = H, R2 = OH
O
iPr2Si
R1
R2
8
Me
 
 Lithium aluminum hydride (4.6 mg, 121 µmol, 7.00 equiv) was added as a solid in a single 
portion to a solution of diisopropylsilyl tethered diol 39 (6.5 mg, 17.3 µmol, 1 equiv) in diethyl ether 
(1.00 mL) at –78 °C and the reaction flask was immediately placed on an ice-water bath.  After 15 
min, saturated aqueous ammonium chloride solution (3 mL) was added, resulting in vigorous gas 
evolution.  The reaction flask was immediately removed from the cooling bath and the reaction 
mixture was allowed to warm at room temperature.  After 5 min, the mixture was diluted with ethyl 
acetate (6 mL), saturated aqueous ammonium chloride solution (2 mL), and water (1.5 mL).  The 
opaque grey aqueous phase (pH 8) was separated and extracted with ethyl acetate (4 × 10 mL).  The 
combined organic phases were washed with brine (3.5 mL), were dried over anhydrous sodium 
sulfate, were filtered, and were concentrated under reduced pressure to a pale yellow residue.  The 
crude dr was determined to be 10:1 by 1H NMR analysis.  This crude residue was purified by flash 
column chromatography on silica gel (eluent: 1.5% triethylamine and 3 → 6% ethyl acetate in 
hexanes, diameter: 1.5 cm, height: 8.5 cm) to afford the azafulvenium ion precursors (5.0 mg, 77%).  
Two batches were obtained: one containing diastereomerically pure 40 (3.8 mg, 58%, >98:2 dr), 
along with a 1:1 mixture of C8 epimers 40 and S4 (1.2 mg, 18%, 1:1 dr). 
1H NMR (500 MHz, C6D6, 20°C): 5.46 (dd, J = 8.8, 6.0 Hz, 1H, C3–H), 4.68 (qd, J = 6.5, 
2.4 Hz, 1H, C9–H), 4.53 (dd, J = 4.5, 2.5 Hz, 1H, C8–
H), 3.11 (tdd, J = 10.7, 4.6, 3.9 Hz, 1H, C4a–H), 2.50 
(dq, J = 14.6, 7.4 Hz, 1H, C11–H), 2.48 (ddd, J = 16.2, 
6.5, 1.0 Hz, 1H, C7–Hc), 2.44 (dq, J = 14.5, 7.3 Hz, 1H, 
C11–H’), 2.38 (ddd, J = 11.1, 6.1, 5.0 Hz, 1H, C4–Hc), 
2.30 (ddd, J = 16.3, 11.7, 6.9 Hz, 1H, C7–Ht), 1.86 (ddd, 
J = 11.2, 10.4, 8.8 Hz, 1H, C4–Ht), 1.74 (heptet, J = 7.6 
Hz, 1H, SiCH(CH3)3), 1.64 (d, J = 4.6 Hz, 1H, C8–OH), 
1.58 (ddddd, J = 13.7, 6.9, 4.1, 2.7, 1.4 Hz, 1H, C6–Ht), 
1.37 (dq, J = 12.5, 3.5 Hz, 1H, C5–Hc), 1.30–1.32 (m, 
6H, C10–H, C12–H), 1.28–1.33 (m, 1H, SiCH(CH3)3), 
1.28 (d, J = 7.6 Hz, 3H, SiCH(CH3)3), 1.26 (d, J = 7.6 
Hz, 3H, SiCH(CH3)3), 1.18–1.30 (m, 1H, C6–Hc), 1.16–
1.19 (m, 6H, SiCH(CH3)3), 0.79 (tdd, J = 12.9, 11.1, 2.4 
Hz, 1H, C5–Ht). 
13C NMR (125.8 MHz, C6D6, 20°C): 132.4, 123.4, 119.0, 113.7, 74.8, 71.6, 71.4, 53.9, 47.4, 
29.9, 22.4, 21.5, 20.7, 19.3, 18.9, 18.8, 18.2, 18.2, 17.6, 
13.9, 13.8. 
FTIR (neat) cm–1: 3588 (w, O–H), 2928 (s), 1436 (m), 1361 (m), 1094 (s). 
HRMS–EI (m/z): calcd for C21H35NO3SiNa [M + Na]+: 400.2278, 
  found: 400.2265. 
TLC (10% EtOAc–hexanes), Rf: 0.25 (CAM). 
Efficient and Stereoselective Dimerization of Pyrroloindolizine Derivatives Inspired by a Hypothesis for the Biosynthesis of Page S13 / S70 
Complex Myrmicarin Alkaloids. 
Mohammad Movassaghi,* Alison E. Ondrus, and Bin Chen 
Heterodimer 43:
O
N
N
Me
Me
O
Me
iPr2
Si
H
H
H
Me
43
N
Me
H
OH
O
O
iPr2Si
N
Me
Me
H
240
+
Sc(OTf)3
CD3CN
23 °C, 4 h
>90%
Me
 
 An anhydrous mixture of (+)-2 (7.6 mg, 35.3 µmol, 2.00 equiv) and alcohol 40 (6.7 mg, 17.7 
µmol, 1 equiv) was transferred in acetonitrile-d3 (250 + 2 × 150 µL) to a sealed, argon-purged NMR 
tube.  To this solution was added a solution of scandium trifluoromethanesulfonate (0.871 mg, 0.177 
µmol, 0.100 equiv) in acetonitrile–d3 (5.0 µL) via syringe, producing an intense yellow color.  After 
10 min, an additional portion of scandium trifluoromethanesulfonate (0.871 mg, 0.177 µmol, 0.100 
equiv) in acetonitrile–d3 (5.0 µL) was added, producing a white precipitate.  After an additional 1h, 
four portions of scandium trifluoromethanesulfonate (0.435 mg, 0.177 µmol, 0.100 equiv) in 
acetonitrile–d3 (2.5 µL) were added at 10 min intervals.  When 1 h and 20 min had elapsed since the 
last portion of scandium trifluoromethanesulfonate had been added, 1H NMR analysis showed clean 
and complete conversion to the desired and air-senstivie heterodimeric product (>90%, 1H NMR) 
with only remaining 2 (~45%, 1H NMR).  Triethylamine (5.0 µL, 35.4 µmol, 2.00 equiv) was added 
to the opaque, bright yellow sample, producing additional white precipitate.  The mixture was then 
transferred under argon to a 5-mL pear-shaped flask, the transfer was completed with acetonitrile-d3 
(2 × 250 µL), and the suspension was concentrated under reduced pressure on an argon/high vacuum 
manifold (final volume approximately 150 µL).  This deep orange suspension was immediately 
purified by flash column chromatography on silica gel (eluent: 2.5% triethylamine and 2.5% ethyl 
acetate in hexanes, diameter: 1.5 cm, height: 4.0 cm) to yield the sensitive heterodimer 43 and co-
eluting 2 (5:1) as a colorless oil that had to be rapidly secured for detailed analysis (including 
gCOSY, NOESY, and HSQC) due to sensitivity to oxidation. 
1H NMR (500 MHz, C6D6, 20°C): 4.74 (t, J = 6.2 Hz, 1H, C4–H), 4.65 (dd, J = 5.6, 3.7 Hz, 
1H, C8–H), 4.48 (qd, J = 6.9, 1.4 Hz, 1H, C9–H), 3.32 
(tdd, J = 10.7, 5.0, 3.7 Hz, 1H, C4a’–H), 3.18 (d, J = 8.5 
Hz, 1H, C1–H), 3.11 (ddd, J = 13.8, 7.3, 6.4 Hz, 1H, 
C5a–H), 2.93 (ddd, J = 14.9, 11.1, 6.3 Hz, 1H, C3’–Hc), 
2.52–2.80 (m, 6H, C11’–H, C11’–H’, C3–H, C7’–Hc, 
C3’–Ht, C2–H), 2.45 (ddd, J = 16.1, 11.7, 6.5 Hz, 1H, 
C7’–Ht), 2.27 (dq, J = 14.4, 7.3 Hz, 1H, C11–H), 2.25 
(dq, J = 14.3, 7.3 Hz, 1H, C11–H’), 2.01–2.14 (m, 4H, 
C5–Hc, C5–Ht, C7–Hc, C7–Ht), 1.84 (dq, J = 12.7, 6.3 
Hz, 1H, C6–Hc), 1.59–1.71 (m, 2H, C6’–Ht, C4’–Ht), 
1.56 (d, J = 7.3 Hz, 3H, C10’–H), 1.49–1.54 (m, 1H, 
C5’–Hc), 1.45 (d, J = 6.9 Hz, 3H, C10–H), 1.41–1.47 
(m, 1H, C6–Ht), 1.41 (t, J = 7.5 Hz, 3H, C12’–H), 1.28–
1.36 (m, 8H, SiCH(CH3)3, SiCH(CH3)3), 1.21 (t, J = 7.6 
Hz, 3H, C12–H), 1.12–1.25 (m, 1H, C6’–Hc), 1.12–1.17 
(m, 3H, SiCH(CH3)3), 0.88 (tdd, J = 13.3, 11.8, 3.0 Hz, 
1H, C5’–Ht). 
13C NMR (125.8 MHz, C6D6, 20°C): 154.7, 148.5, 136.0, 126.0, 122.4, 119.3, 113.5, 90.2, 
89.8, 86.7, 73.4, 55.3, 55.3, 53.3, 49.4, 47.0, 41.4, 37.2, 
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30.8, 30.2, 27.4, 26.2, 24.6, 23.1, 21.1, 21.0, 19.7, 18.9, 
18.6, 18.4, 18.3, 18.1, 17.0, 14.2, 12.8, 12.1. 
FTIR (neat) cm–1: 2940 (s), 1730 (m), 1668 (m), 1461 (m), 1095 (m). 
HRMS–EI (m/z): calcd for C36H55N2O2Si [M + H]+: 575.4027, 
  found: 575.4043. 
TLC (Et3N–pretreated silica, 2.5% Et3N, 2.5% EtOAc–hexanes), Rf:  0.76 (UV, CAM). 
                                      
N
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 1-(1-Ethyl-3-hydroxy-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl)-2-hydroxy-propan-1-one 
(45): Tetrabutylammonium fluoride (1.0 M in THF, 100 µL, 100 µmol, 1.67 equiv) was added via 
syringe to a solution of triisopropylsilyl ether 44 (24.9 mg, 59.3 µmol, 1 equiv) in tetrahydrofuran 
(2.00 mL) at 0 °C.  After 20 min, chloroform (5 mL) and aqueous sodium chloride solution (10 wt%, 
5 mL) were added simultaneously to the pale yellow solution and the reaction flask was immediately 
removed from the cooling bath.  The mixture was diluted with additional portions of chloroform (10 
mL) and aqueous sodium chloride solution (10 wt%, 5 mL).  The aqueous layer was separated and 
extracted with chloroform (5 × 10 mL), and the combined organic layers were washed with brine (7.5 
mL), were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced 
pressure to a pale yellow solution in chloroform (150 µL).  This crude solution was purified by flash 
column chromatography on silica gel (eluent: 65 → 80% ethyl acetate in hexanes, diameter: 2.5 cm, 
height: 3.5 cm) to provide the diol 45 (14.4 mg, 92%) as a white powder. 
1H NMR (500 MHz, CDCl3, 20°C): 5.46 (dd, J = 8.2, 6.4 Hz, 1H, C3–H), 4.97 (q, J = 6.5 
Hz, 1H, C9–H), 4.09 (br s, 1H, C9-OH), 3.90 (dddd, J = 
11.3, 10.1, 5.2, 3.6 Hz, 1H, C4a–H), 3.08 (ddd, J = 11.9, 
6.4, 5.5 Hz, 1H, C4–Hc), 2.97 (br s, 1H, C3–OH), 2.78 
(ddd, J = 16.7, 6.7, 1.1 Hz, 1H, C7–Hc), 2.66 (dq, J = 
14.5, 7.3 Hz, 1H, C11–H), 2.58 (dq, J = 14.4, 7.2 Hz, 
1H, C11–H’), 2.56 (ddd, J = 16.2, 11.8, 6.5 Hz, 1H, C7–
Ht), 2.15–2.22 (m, 2H, C5–Hc, C6–Ht), 2.05 (ddd, J = 
12.0, 10.2, 8.3 Hz, 1H, C4–Ht), 1.71–1.83 (m, 1H, C6–
Hc), 1.43 (d, J = 6.7 Hz, 3H, C10–H), 1.37–1.49 (m, 1H, 
C5–Ht), 1.17 (t, J = 7.5 Hz, 3H, C12–H). 
13C NMR (125.8 MHz, CDCl3, 20°C): 199.6, 142.3, 125.4, 122.3, 113.4, 71.0, 70.6, 55.5, 46.8, 
29.8, 23.5, 22.2, 20.3, 20.0, 16.5. 
FTIR (neat) cm–1: 3331 (s, O–H), 2929 (s, C–H), 1635 (s, C=O), 1448 (s), 
1092 (s). 
HRMS–EI (m/z): calcd for C15H21NO3Na [M + Na]+: 286.1414, 
  found: 286.1424. 
TLC (silica gel, 65% EtOAc–hexanes), Rf: 0.20 (UV, CAM).
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[1,3,2]-Dioxasilocine ketone 46:
N
Me
H
O
O
iPr2SiCl2, DMAP
 DMF
23 °C, 70 min
29%
46
N
Me
H
O
HO
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HO O
iPr2Si
Me Me
 
 Diisopropyldichlorosilane (iPr2SiCl2, 13.6 µL, 75.2 µmol, 1.50 equiv) was added dropwise via 
syringe to a solution of diol 45 (13.2 mg, 50.1 µmol, 1 equiv) and 4-(dimethylamino)pyridine (21.4 
mg, 175 µmol, 3.50 equiv) in dimethylformamide (1.00 mL) at 23 °C, producing a white suspension.  
Additional portions of diisopropyldichlorosilane (6.8 µL, 37.7µmol, 0.750 equiv) and 4-
(dimethylamino)pyridine (21.4 mg, 75.2 µmol, 3.50 equiv) were added after 25 min and 55 min, 
respectively.  After 70 min total reaction time, TLC analysis indicated that the starting material had 
been completely consumed.  Diethyl ether (10 mL) and a mixture of water and saturated aqueous 
sodium bicarbonate solution (7:1, 8 mL) were added.  The aqueous layer was separated and extracted 
with ethyl acetate (3 × 7.5 mL).  The combined organic phases were washed with brine (6 mL), were 
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.  
This residue was purified by flash column chromatography on silica gel (eluent: 2.5% triethylamine 
and 2 → 75% ethyl acetate in hexanes, diameter 1.5 cm, height 22 cm) to afford the diisopropylsilyl 
tethered diol 46 (5.5 mg, 29%) as a colorless oil.  The remainder of the material isolated from the 
column, consisting of a mixture of C3 and C9 mono- and bis-silylated byproducts, was combined and 
diol 45 was recovered by their treatment with tetrabutylammonium fluoride in tetrahydrofuran at 0°C.  
1H NMR (500 MHz, C6D6, 20°C): 5.29 (dd, J = 7.5, 6.6 Hz, 1H, C3–H), 4.90 (q, J = 6.2 
Hz, 1H, C9–H), 3.08 (dq, J = 13.8, 7.1 Hz, 1H, C11–H), 
2.94 (dq, J = 13.8, 7.1 Hz, 1H, C11–H’), 2.83 (tdd, J = 
10.8, 5.9, 3.5 Hz, 1H, C4a–H), 2.47 (dt, J = 12.1, 6.1 Hz, 
1H, C4–Hc), 2.30 (ddd, J = 16.4, 6.6, 1.1 Hz, 1H, C7–
Hc), 2.06 (ddd, J = 16.5, 12.0, 6.9 Hz, 1H, C7–Ht), 1.79 
(ddd, J = 12.1, 10.4, 7.6 Hz, 1H, C4–Ht), 1.66 (d, J = 6.3 
Hz, 3H, C10–H), 1.48 (ddddd, J = 13.7, 6.9, 4.0, 2.7, 1.4 
Hz, 1H, C6–Ht), 1.40 (t, J = 7.5 Hz, 3H, C12–H), 1.36 
(dq, J = 12.5, 3.4 Hz, 1H, C5–Hc), 1.16 (d, J = 7.1 Hz, 
3H, SiCH(CH3)3), 1.13 (d, J = 7.0 Hz, 3H, SiCH(CH3)3), 
1.05–1.12 (m, 1H, C6–Hc), 1.16 (d, J = 7.1 Hz, 3H, 
SiCH(CH3)3), 1.04–1.21 (m, 1H, SiCH(CH3)3), 0.90 (d, J 
= 7.2 Hz, 3H, SiCH(CH3)3), 0.87 (d, J = 7.1 Hz, 3H, 
SiCH(CH3)3), 0.77–0.81 (m, 1H, C5–Ht), 0.76–0.86 (m, 
1H, SiCH(CH3)3). 
13C NMR (125.8 MHz, C6D6, 20°C): 192.4, 136.4, 128.9, 121.0, 115.8, 72.5, 71.6, 53.3, 47.3, 
29.6, 22.2, 19.9, 19.7, 18.6, 17.8, 17.7, 17.6, 17.4, 16.1, 
13.5, 13.3. 
FTIR (neat) cm–1: 2931 (s), 2866 (s), 1666 (s, C=O), 1445 (m) , 1110 (s). 
HRMS–EI (m/z): calcd for C21H33NO3SiNa [M + Na]+: 398.2122, 
  found: 398.2112. 
TLC (silica gel, 12.5% EtOAc–hexanes), Rf:  0.22 (UV, CAM). 
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 [1,3,2]-Dioxasilocine alcohol 47: 
 Lithium aluminum hydride (11.9 mg, 313 µmol, 10.00 equiv) was added as a solid in a single 
portion to a solution of ketone 46 (11.8 mg, 31.3 µmol, 1 equiv) in diethyl ether (Et2O, 1.60 mL) at 0 
°C. After 10 min, the mixture was diluted with saturated aqueous ammonium chloride solution (4 
mL) and ethyl acetate (3 mL), and the reaction flask was immediately removed from the cooling bath.  
The reaction mixture was stirred at room temperature for 5 min, then diluted with additional portions 
of ethyl acetate (50 mL) and saturated aqueous ammonium chloride solution (50 mL).  The opaque 
grey aqueous phase (pH 7) was separated and extracted with ethyl acetate (4 × 40 mL).  The 
combined organic phases were washed with brine (35 mL), were dried over anhydrous sodium 
sulfate, were filtered, and were concentrated under reduced pressure.  The white residue was purified 
by flash column chromatography on silica gel (eluent: 2.5% triethylamine and 5% ethyl acetate in 
hexanes changed gradually to 2.5% triethylamine and 3.5% methanol in ethyl acetate, diameter: 1.5 
cm, height: 10 cm) to afford the sensitive alcohol 47 (1.9 mg, 16%) as a colorless oil.  The remainder 
of the material isolated from the column consisted of recovered starting material (1.0 mg, 8.4%) and 
the fully desilylated C3-C8-C9 triol (2.9 mg, 24%). 
1H NMR (500 MHz, C6D6, 20°C): 5.25 (dd, J = 7.3, 6.7 Hz, 1H, C3–H), 4.60 (d, J = 11.4 
Hz, 1H, C8–H), 4.48 (q, J = 6.3 Hz, 1H, C9–H), 3.03 
(tdd, J = 10.8, 5.4, 3.2 Hz, 1H, C4a–H), 2.97 (dq, J = 
14.7, 7.6 Hz, 1H, C11–H), 2.74 (dq, J = 14.3, 7.3 Hz, 
1H, C11–H’), 2.51 (ddd, J = 11.7, 6.3, 5.5 Hz, 1H, C4–
Hc), 2.49 (d, J = 11.4 Hz, 1H, C8–OH), 2.48 (ddd, J = 
16.3, 6.7, 1.3 Hz, 1H, C7–Hc), 2.27 (ddd, J = 16.3, 11.9, 
6.8 Hz, 1H, C7–Ht), 1.91 (ddd, J = 11.7, 10.6, 7.5 Hz, 
1H, C4–Ht), 1.59 (ddddd, J = 13.7, 6.8, 4.0, 2.7, 1.4 Hz, 
1H, C6–Ht), 1.46 (d, J = 6.3 Hz, 3H, C10–H), 1.42–1.46 
(m, 1H, C5–Hc), 1.40 (t, J = 7.5 Hz, 3H, C12–H), 1.23 
(tddd, J = 13.4, 12.1, 6.5, 3.0 Hz, 1H, C6–Hc), 1.12–1.15 
(m, 6H, SiCH(CH3)3), 1.06–1.15 (m, 1H, SiCH(CH3)3), 
0.98 (d, J = 7.1 Hz, 3H, SiCH(CH3)3), 0.85–0.91 (m, 1H, 
C5–Ht), 0.82–0.95 (m, 1H, SiCH(CH3)3). 
13C NMR (125.8 MHz, C6D6, 20°C): 128, 125.2, 119.4, 118.0, 71.5, 71.1, 70.8, 52.7, 47.4, 
29.8, 22.8, 22.6, 20.6, 19.4, 18.1, 18.0, 18.0, 17.8, 16.6, 
12.8, 12.4. 
 
HRMS–EI (m/z): calcd for C21H35NO3SiNa [M + Na]+: 400.2278, 
  found: 400.2281. 
 
TLC (silica gel, 10% EtOAc–hexanes), Rf: 0.36 (CAM). 
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Heterodimer 49:  
 An anhydrous solution of (+)-myrmicarin 215B (2, 1.1 mg, 5.01 µmol, 1.00 equiv) in 
acetonitrile–d3 (500 µL) was added portionwise to an anhydrous solution of alcohol 47 (1.9 mg, 5.01 
µmol, 1 equiv) in acetonitrile–d3 (250 µL) until 1H NMR analysis showed that the ratio of the two 
species was exactly 1:1.  This solution was concentrated (final volume 150 µL) and transferred under 
argon to a sealed, argon-purged NMR tube, followed by an acetonitrile–d3 (2 × 30 µL) rinse of the 
transfer flask.  To this solution, scandium trifluoromethanesulfonate (0.246 mg, 0.501 µmol, 0.100 
equiv) in acetonitrile–d3 (5.0 µL) was added via syringe, producing an intense yellow color.  After 10 
min, an additional two portions of scandium trifluoromethanesulfonate (2 × 0.246 mg, 0.501µmol, 
0.100 equiv) were added at 10 min intervals.  When 10 min had elapsed since the last portion of 
scandium trifluoromethanesulfonate was added, 1H NMR analysis showed complete and clean 
formation of the desired heterodimer 49 (>90%) as a single diastereomer and trace amount of 
remaining 2 (<5%).  Triethylamine (5.0 µL, 35.9 µmol, 7.16 equiv) was added to the intense yellow 
solution, producing a small amount of precipitate.  The sample was transferred under argon to a 5-mL 
pear-shaped flask, the NMR tube was rinsed with acetonitrile–d3 (2 × 100 µL), and the suspension 
was concentrated under reduced pressure on an argon/high vacuum manifold (final volume ~200 µL).  
This sample was directly purified by flash column chromatography on a silica gel (eluent: 2.5% 
triethylamine and 2.5% ethyl acetate in hexanes, diameter: 1.0 cm, height: 2.5 cm) to afford the 
sensitive heterodimer 49 and myrmicarin 215B (>95:5) as a colorless oil that had to be rapidly 
secured for detailed analysis (including gCOSY, gHSQC, NOESY, and gHMBC) due to sensitivity to 
oxidation. 
1H NMR (500 MHz, C6D6, 23°C): 4.66 (dd, J = 7.5, 3.0 Hz, 1H, C8–H), 4.28 (d, J = 4.3 
Hz, 1H, C4–H), 4.11 (qd, J = 8.9, 5.8 Hz, 1H, C9–H), 
3.30 (tdd, J = 10.6, 5.3, 3.5 Hz, 1H, C4a’–H), 3.18 
(dddd, J = 11.6, 9.3, 6.4, 2.1 Hz, 1H, C5a–H), 2.95 (ddd, 
J = 15.2, 11.1, 6.2 Hz, 1H, C3’–Hc), 2.56–2.71 (m, 5H, 
C3–H, C7’–Hc, C3’–Ht, C11’–H, C11’–H’), 2.53 (d, J = 
9.0 Hz, 1H, C1–H), 2.45 (dq, J = 14.6, 7.4 Hz, 1H, C11–
H), 2.31–2.49 (m, 3H, C7–Ht, C5–Hc, C2–H), 2.27 (dq, J 
= 14.6, 7.4 Hz, 1H, C11–H’), 2.16 (ddt, J = 15.2, 11.9, 
3.3 Hz, 1H, C7–Ht), 2.06 (dt, J = 11.4, 5.9 Hz, 1H, C4’–
Hc), 2.04–2.12 (m, 1H, C2–H), 1.95 (dd, J = 13.7, 1.8 
Hz, 1H, C5–Ht), 1.56–1.68 (m, 3H, C6’–Ht, C4’–Ht, C6–
Hc), 1.51 (td, J = 11.8, 4.0 Hz, 1H, C6–Ht), 1.42–1.48 
(m, 1H, C5’–Hc), 1.35 (t, J = 7.5 Hz, 3H, C12’–H), 1.32 
(d, J = 5.8 Hz, 3H, C10–H), 1.27 (t, J = 7.5 Hz, 3H, 
C12–H), 1.24–1.32 (m, 2H, C6’–Hc, SiCH(CH3)3), 1.17 
(d, J = 7.4 Hz, 3H, SiCH(CH3)3), 1.14 (d, J = 7.4 Hz, 
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3H, SiCH(CH3)3), 1.09–1.14 (m, 6H, SiCH(CH3)3), 
1.08–1.18 (m, 1H, SiCH(CH3)3), 0.99 (d, J = 7.0 Hz, 3H, 
C10’–H), 0.82 (tdd, J = 13.1, 11.7, 3.3 Hz, 1H, C5’–Ht). 
13C NMR (125.8 MHz, C6D6, 23°C): 154.3 (C8a), 145.9 (C3a), 134.1 (C8b), 131.2 (C2a’), 
121.9 (C1’), 116.8 (C7a’), 113.4 (C2’), 91.4 (C3b), 87.1 
(C8), 84.7 (C4), 67.7 (C9), 55.3 (C4a’), 55.0 (C5a), 50.2 
(C3), 49.7 (C2), 48.2 (C1), 43.5 (C5), 37.2 (C4’), 31.1 
(C6), 30.1 (C5’), 27.4 (C3’), 25.9 (C10), 23.3 (C7), 23.2 
(C6’), 21.3 (C7), 19.6 (C11), 19.2 (C11’), 18.6 
(SiCH(CH3)3), 18.5 (SiCH(CH3)3, 18.2 (SiCH(CH3)3, 
18.2 (SiCH(CH3)3, 17.8 (C12’), 17.3 (C10’), 14.3 (C12), 
12.1 (SiCH(CH3)3, 11.5 (SiCH(CH3)3. 
FTIR (neat) cm–1: 2929 (s), 1717 (m), 1653 (m), 1507 (w), 1118 (m). 
HRMS–EI (m/z): calcd for C36H55N2O2Si [M + H]+: 575.4027, 
  found: 575.4033. 
TLC (Et3N–pretreated silica, 2.5% Et3N, 2.5% EtOAc–hexanes), Rf:  0.82 (UV, CAM). 
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1-(1-Ethyl-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl)-2-hydroxy-propan-1-one (58):   
 An anhydrous solution of ketone 56 (97.3 mg, 421 µmol, 1 equiv) in tetrahydrofuran (2500 + 
2 × 250 µL) was added via cannula to a solution of potassium bis(trimethylsilyl)amide (KHMDS, 209 
mg, 1.05 mmol, 2.50 equiv) in tetrahydrofuran (750 µL) at –78 °C , producing a clear and pale yellow 
solution.  After 15 min, a solution of (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine8 (110 mg, 421 
µmol, 1.00 equiv) in tetrahydrofuran (440 µL) was added dropwise via syringe.  After 5 min, two 
additional portions of (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine (11.0 mg, 42.1 µmol, 0.100 
equiv) in tetrahydrofuran (44.0 µL) were added at 5 min intervals.  When 5 min had elapsed after the 
last addition, a mixture of saturated aqueous sodium thiosulfate solution and saturated aqueous 
sodium bicarbonate solution (1:1, 3 mL) was added to the yellow reaction mixture and the reaction 
flask was immediately removed from the cooling bath.  The mixture was diluted with ethyl acetate 
(20 mL) and an additional portion of saturated aqueous sodium thiosulfate solution-saturated aqueous 
sodium bicarbonate solution (1:1, 12 mL), and the aqueous phase was extracted with ethyl acetate (4 
× 15 mL).  The combined organic phases were washed with brine (12.5 mL), were dried over 
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure to a yellow 
solution in ethyl acetate (approximately 300 µL).  This sample was directly purified by flash column 
chromatography on silica gel (eluent: 2.5% triethylamine, 37.5% ethyl acetate, and 15% 
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dichloromethane in hexanes, diameter: 2.5 cm, height: 17 cm) to afford the α-hydroxy ketone 58 
(78.0 mg, 75%, mixture of C9 epimers, 9:5 dr) as a while powder.  
 
1H NMR (500 MHz, C6D6, 20°C, 9:5 dr, major epimer denoted by *):  4.67–4.78 (m, 2H, C9–H*, C9–
H), 4.55–4.57 (m, 2H, C9–OH*, C9–OH), 2.85–3.17 
(m, 6H, C11–H*, C11–H’*, C11–H, C11–H’, C4a–H*, 
C4a–H), 2.04–2.42 (m, 8H, C3–Ht*, C3–Ht, C7–Hc*, 
C7–Hc, C3–Hc*, C3–Hc, C7–Ht*, C7–Ht), 1.65–1.71 (m, 
2H, C4–Hc*, C4–Hc), 1.47–1.56 (m, 2H, C6–Ht*, C6–
Ht), 1.42–1.46 (m, 12H, C12–H*, C12–H, C10–H*, 
C10–H), 1.19–1.39 (m, 4H, C4–Ht*, C4–Ht, C5–Hc*, 
C5–Hc), 1.07–1.18 (m, 2H, C6–Hc*, C6–Hc), 0.59–0.69 
(C5–Ht*, C5–Ht*). 
13C NMR (125.8 MHz, C6D6, 20°C, 9:5 dr, major epimer denoted by *):  197.3*, 197.2, 138.1, 
138.1*, 126.7*, 126.5, 121.7, 121.5*, 113.3, 113.2*, 
70.5, 70.1*, 56.1*, 56.0, 36.3, 35.9*, 29.5, 29.4*, 28.3, 
28.0*, 23.9*, 23.8, 22.6*, 22.3, 20.1, 20.1*, 19.9*, 19.8, 
16.3*, 16.1. 
FTIR (neat) cm–1: 3451 (m, O–H), 2921 (s), 1632 (s, C=O), 1460 (m), 
1370 (m), 1039 (m). 
HRMS–EI (m/z): calcd for C15H21NO2Na [M + Na]+: 270.1465, 
  found: 270.1469. 
TLC (2.5% Et3N, 17.5% EtOAc, 20% CH2Cl2–hexanes), Rf:  0.21 (UV, CAM). 
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1,3-Bis-(1-ethyl-3,4,4a,5,6,7-hexahydro-pyrrolo[2,1,5-cd]indolizin-2-yl)-2-methyl-pentan-1,4-dione (61): 
 To a degassed solution (argon purge, 15 min) of methyl ether 60 (140 mg, 304 µmol, 1 equiv) 
in benzene (10.0 mL) was added a degassed solution (argon purge, 15 min) of pyridinium p-
toluenesulfonic acid (PPTS, 115 mg, 456 µmol, 1.50 equiv) and deionized water (H2O, 15.0 µL, 832 
µmol, 2.74 equiv) in acetonitrile (1.00 mL).  The resulting deep orange fine suspension was sonicated 
for 30 min, then saturated aqueous sodium bicarbonate solution (15 mL) was added and the mixture 
was diluted with ethyl acetate (25 mL).  The aqueous phase was separated and extracted with ethyl 
acetate (3 × 20 mL).  The combined organic phases were washed with brine (12.5 mL) and were dried 
over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.  The red 
residue was purified by flash column chromatography on silica gel (eluent: 1% triethylamine and 17.5 
→ 35% ethyl acetate in hexanes, diameter: 2.5 cm, height: 24 cm) to provide the air-sensitive 
diketone 61 (94.5 mg, 70%, nearly equal mixture of stereoisomers) as an off-white solid. 
 
1H NMR (500 MHz, C6D6, 20°C, mixture of 4 stereoisomers, 1.20:1:1.20:1.22 dr): 4.62 (d, J = 10.9 
Hz, 1H, C3–H), 4.56 (d, J = 10.5 Hz, 1H, C3–H), 4.46 
(d, J = 10.4 Hz, 1H, C3–H), 4.38 (d, J = 10.4 Hz, 1H, 
C3–H), 3.95–4.14 (m, 4H), 1.80–3.50 (m, 64H), 2.16 (s, 
3H, C10–H), 2.11 (s, 3H, C10–H), 2.08 (s, 3H, C10–H), 
2.02 (s, 3H, C10–H), 1.20–1.70 (m, 60H), 0.54–1.18 (m, 
16H). 
13C NMR (125.8 MHz, C6D6, 20°C, mixture of 4 stereoisomers, 1.20:1:1.20:1.22 dr):  207.8, 207.2, 
206.4, 206.3, 200.0, 199.9, 198.1, 198.0, 137.4, 137.4, 
136.8, 136.7, 129.3, 129.0, 128.9, 128.0, 126.4, 126.2, 
126.2, 125.8, 122.8, 122.6, 122.2, 122.2, 120.9, 120.8, 
120.8, 120.7, 119.4, 119.4, 119.3, 119.1, 118.0, 117.4, 
117.0, 116.8, 110.8, 110.3, 109.8, 109.4, 56.0, 55.9, 
55.9, 55.9, 55.6, 55.4, 55.4, 55.2, 53.1, 52.6, 52.4, 52.4, 
46.6, 46.2, 46.0, 45.2, 37.4, 37.4, 37.3, 37.3, 36.7, 36.2, 
36.1, 36.0, 30.6, 30.4, 30.1, 30.0, 30.0, 29.9, 29.7, 29.7, 
29.6, 29.5, 28.7, 28.6, 28.4, 28.4, 26.5, 25.7, 23.1, 23.1, 
23.1, 22.9, 22.9, 22.8, 22.7, 22.7, 22.5, 21.1, 21.0, 21.0, 
21.0, 20.3, 20.2, 20.1, 20.1, 20.1, 19.9, 19.9, 19.9, 19.2, 
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19.2, 19.0, 19.0, 18.9, 18.7, 18.5, 18.0, 17.8, 17.1, 17.0, 
16.7, 16.7, 16.4, 16.4, 16.4, 16.3, 16.2, 16.2. 
FTIR (neat) cm–1: 2928 (s, C–H), 1706 (s, C=O), 1641 (s, C=O), 1497 (s), 
1428 (s), 1321 (s), 1167 (m). 
 
HRMS–EI (m/z): calcd for C30H41N2O2 [M + H]+: 461.3163,                       
found: 461.3149. 
 
TLC (1% Et3N, 20% EtOAc–hexanes), Rf:  0.33 (UV, CAM).
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NOESY Correlations for heterodimers 43 and 49. 
NOESY correlations Proton signal 43 49 
C1–H C4–H, C10'–CH3, C11'-CH2 C4–H, C9–H, C10’–CH3 
C2–H C3–H, C10’–CH3 C3–H, C10’–CH3 
C3–H C2–H, C9–H, C10–CH3 C2–H, C10–CH3, C12–CH3 
C4–H C1–H, C5a–H, C5–Hc/C5–Ht C1–H, C5–Hc, C9–H 
C5–Hc C4–H, C5a–H, C5–Ht 
C5–Ht 
C4–H, C5a–Ha C4–H, C5–Ht, C6–Ht 
C5a–H C4–H, C5–Hc/C5–Ht C5–Hc, C6–Hc 
C6–Hc C5a–H, C6–Ht, C7–Hc/C7–Ht C5a–H, C6–Ht, C7–Hc 
C6–Ht C6–Hc, C7–Hc/C7–Ht C5–Ht, C6–Hc, C7–Ht 
C7–Hc C6–Hc, C7–Ht, C8–H 
C7–Ht 
C6–Hc, C6–Ht, C8–Hb C6–Ht, C7–Hc 
C8–H C7–Hc/C7–Ht, C11–H C7–Hc, C11–CH2, C12–CH3 
C9–H C3–H, C10–CH3 C1–H, C4–H, C10–CH3, C10’–CH3 
C10–CH3 C3–H, C9–H C3–H, C9–H, C10’–CH3 
C11–H C8–H, C12–CH3 
C11–H’ C12–CH3 C8–H, C12–CH3
c 
C12–CH3 C11–H C3–H, C11–CH2 
C10’–CH3 C1–H, C2–H C1–H, C2–H, C10–CH3 
C3’–Hc C3’–Ht, C4’–Hc C3’–Ht, C4’–Hc 
C3’–Ht C3’–Hc, C4’–Ht C3’–Hc, C4’–Ht 
C4’–Hc C3’–Hc, C4’–Ht, C4a’–H C3’–Hc, C4a’–H, C4’–Ht 
C4’–Ht C3’–Ht, C4’–Hc C3’–Ht, C4’–Hc 
C4a’–H C4’–Hc, C5’–Hc, C6’–Hc C4’–Hc, C5’–Hc, C6’–Hc 
C5’–Hc C4a’–H, C6’–Hc, C6’–Ht C4a’–H, C6’–Ht 
C5’–Ht C5’–Hc, C6’–Ht C5’–Hc, C6’–Ht 
C6’–Hc C4a’–H, C6’–Ht, C7’–Hc C4a’–H, C6’–Ht, C7’–Hc 
C6’–Ht C6’–Hc, C7’–Ht C5’–Hc, C5’–Ht, C6’–Hc, C7’–Ht 
C7’–Hc C6’–Hc, C7’–Ht C6’–Hc, C6’–Ht, 7't 
C7’–Ht C6’–Ht, C7’–Hc C7’–Hc 
C11’–CH2 C1–H, C12’–CH3 C12’–CH3 
C12’–CH3 C11’–CH2 C11’–CH2 
aSignals for protons C5–Hc and C5–Ht overlap in the 1H NMR spectrum of 43. bSignals for protons 
C7–Hc and C7–Ht overlap in the 1H NMR spectrum of 43. cSignals for protons C11–H and C11–H’ 
overlap in the 1H NMR spectrum of 49. 
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Summary of key correlations: 
 
 
Key correlations for assignment of C1, C2, 
C3 stereochemistry of heterodimer 43: 
 
N
N
Me
Me
Me
O
H
H
O
iPr2Si
H
H
H
1
4
3
10'
H
43
Me
H 2
 
Key correlations for assignment of C9 
stereochemistry of heterodimer 43: 
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Key correlations for assignment of C1, C2, 
C3 stereochemistry of heterodimer 49: 
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Key correlations for assignment of C9 
stereochemistry of heterodimer 49: 
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